These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29046987)

  • 41. Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study.
    Tsuchida-Nishiwaki M; Uchida HA; Takeuchi H; Nishiwaki N; Maeshima Y; Saito C; Sugiyama H; Wada J; Narita I; Watanabe T; Matsuo S; Makino H; Hishida A; Yamagata K
    Sci Rep; 2021 Jul; 11(1):14990. PubMed ID: 34294784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of SPRINT on the future treatment of hypertension: a mini review.
    Chrysant SG
    Drugs Today (Barc); 2016 Mar; 52(3):193-8. PubMed ID: 27186593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Value of Reverse Dipper Blood Pressure Pattern in Chronic Kidney Disease Patients not Undergoing Dialysis: Prospective Cohort Study.
    Wang C; Ye Z; Li Y; Zhang J; Zhang Q; Ma X; Peng H; Lou T
    Sci Rep; 2016 Oct; 6():34932. PubMed ID: 27713498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Elusive Search for Optimal Blood Pressure Targets.
    Gradman AH
    Curr Hypertens Rep; 2017 Aug; 19(8):63. PubMed ID: 28707234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of blood pressure with cardiovascular outcome and mortality: results from the KNOW-CKD study.
    Lee JY; Park JT; Joo YS; Lee C; Yun HR; Chang TI; Kim YH; Chung W; Yoo TH; Kang SW; Park SK; Chae DW; Oh KH; Han SH
    Nephrol Dial Transplant; 2022 Aug; 37(9):1722-1730. PubMed ID: 34473286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma microRNA-155-5p is increased among patients with chronic kidney disease and nocturnal hypertension.
    Klimczak D; Kuch M; Pilecki T; Żochowska D; Wirkowska A; Pączek L
    J Am Soc Hypertens; 2017 Dec; 11(12):831-841.e4. PubMed ID: 29146158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aggressive systolic blood pressure control in older subjects: benefits and risks.
    Chrysant SG
    Postgrad Med; 2018 Mar; 130(2):159-165. PubMed ID: 29375010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
    Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
    Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.
    Gorostidi M; Sarafidis PA; de la Sierra A; Segura J; de la Cruz JJ; Banegas JR; Ruilope LM;
    Am J Kidney Dis; 2013 Aug; 62(2):285-94. PubMed ID: 23689071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?
    Khouri Y; Steigerwalt SP; Alsamara M; McCullough PA
    Curr Cardiol Rep; 2011 Dec; 13(6):492-501. PubMed ID: 21887524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-Varying Association of Individual BP Components with eGFR in Late-Stage CKD.
    Sood MM; Akbari A; Manuel D; Ruzicka M; Hiremath S; Zimmerman D; McCormick B; Taljaard M
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):904-911. PubMed ID: 28356338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population.
    Tantisattamo E; Hamiduzzaman A; Sohn P; Ahdoot R; Hanna RM
    Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):57-62. PubMed ID: 34750334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circadian blood pressure patterns and blood pressure control in patients with chronic kidney disease.
    Di Daniele N; Fegatelli DA; Rovella V; Castagnola V; Gabriele M; Scuteri A
    Atherosclerosis; 2017 Dec; 267():139-145. PubMed ID: 29128778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.
    Chang TI; Tabada GH; Yang J; Tan TC; Go AS
    J Hypertens; 2016 Feb; 34(2):244-52. PubMed ID: 26599220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease.
    Yokota K; Fukuda M; Matsui Y; Hoshide S; Shimada K; Kario K
    Hypertens Res; 2013 Feb; 36(2):151-7. PubMed ID: 23013884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
    Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
    Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What should be the goal blood pressure in nondiabetic chronic kidney disease?
    Schneider MP; Hilgers KF
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):180-5. PubMed ID: 24401787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?
    Wheeler DC; Becker GJ
    Kidney Int; 2013 Mar; 83(3):377-83. PubMed ID: 23325075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols.
    Drawz PE; Ix JH
    J Am Soc Nephrol; 2018 Feb; 29(2):383-388. PubMed ID: 29051347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.